NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/17/2024
Back to search
Official data from USPTO
BEAUFORT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000097753728Class
35, 40, 42, 45
Filing
97753728
Registration
7509253
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
09/17/2024
Trademark type
Combined
Nice classes
35, 40, 42, 45
Filing date
01/13/2023
Registration date
09/17/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/17/2024
Last transaction
09/17/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
12/05/2022
First use in commerce
12/05/2022
Drawing code
3
Owner type
16
Owner location
Virginia Beach, VA
Examiner
FRENCH, CURTIS
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of an image comprised of the shape of a light-blue, 90-degree angle open to the right and facing the shape of a dark-blue, 90-degree angle open to the left, the two angles having the shape of a green sphere centered between them, and the word "BEAUFORT" written in dark-blue letters to the right of the image.
Holders and representatives
Holders
BEAUFORT, LLC
Representatives
WILLCOX & SAVAGE, P.C.
Technical classification
Nice Classes
Class 35Class 40Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Regulatory submission managementassisting others in preparing Investigational New Drug applications (INDs) and New Drug Applications (NDAs) for submission to the FDA; database management; organizing and administering a network of research sitesbusiness consultation and management in the field of clinical trialsspecificallyproviding governmental registration assistance in the nature of regulatory submission management on behalf of research sites that conduct gene therapy and vaccine research to assist them with clinical research and clinical trials; providing institutional biosafety committee servicesproviding independent review and oversight of clinical trials involving genetically engineered gene therapy and vaccine research for business purposes
Class 40
Consulting services in the field of manufacturing compliance and validationproviding technical advice related to the manufacture of pharmaceuticals
Class 42
Contract research organization (CRO) servicesmonitoring of clinical trials for investigational drugs of biotech and pharmaceutical companiesclinical trial project management and quality assurancemedical writing of investigational drug protocolsmedical research in the nature of biostatistical analysis; consulting services in the field of conducting clinical trialsdrug developmentmanufacturing environmental compliance and validationadvanced technology in the pharmaceutical fieldmedical research in the nature of clinical benchmarking used to improve the performance of professionals in the fields of international healththe pharmaceutical industrythe biotechnology industry and the medical device and diagnostics industries; providing quality assurance services in the field of regulatory submissions to the FDA by life sciences companies to ensure validity and accuracy; product development for othersproviding implementation services relating to the development and validation of drugsdevices and biologics; providing institutional biosafety committee servicesreview and oversight of clinical trials involving genetically engineered gene therapy and vaccine researchspecificallyevaluating research sites involved in gene therapy and vaccine research clinical trials to determine whether the organizations conform to an established accreditation standard; assessing the readiness of research sites to conduct gene therapy and vaccine researchtestinganalysisevaluation of gene therapy and vaccine research service providers to determine conformity with established accreditation standards; consultation services in the nature of quality managementquality evaluation and analysisquality assurancequality control in the field of clinicalmedicalbiological research studies; consultation services in the field of drug and medical device development; consultation services in the field of conducting clinical trials for others; consultation services in the field of scientific research complianceanalysis and evaluation of scientific research of others in the field of clinical trials involving human subjects to assure compliance with industry standards; consultation services in the field of scientific research administration and operations in the field of clinical trials involving human subjects; consultation services in the field of product research and development and scientific research and development
Class 45
Legal researchregulatory research in the pharmaceutical industrybiotechnology industry and the medical and diagnostics industry; consultation in the field of regulatory compliance to ensure validity and accuracy of regulatory submissions to the FDA by life sciences companies; conducting regulatory and compliance audits for othersreviewing standards and practices to assure compliance with laws and regulations in the fields of pharmaceuticalveterinarypharmacogenomicbiotechnical and medical products and devices; providing information relating to legal affairsproviding regulatory information relating to the development and validation of drugsdevices and biologics; regulatory compliance consulting as it applies to clinical trialsmonitoring by clinical research administrators for compliance with regulations governing clinical trials; legal document preparation servicespreparation of Investigational New Drug applications (INDs) and New Drug Applications (NDAs) for submission to the FDA; consulting services in the field of regulatory affairs and manufacturing compliance and validationregulatory compliance consulting as it applies to prescription drug sampling; consulting services in the field of clinical benchmarking and performance improvementproviding independent review of clinical trials involving human subjects in the nature of reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research; providing regulatory compliance consultation services in the nature of advice concerning due diligencestrategic developmentregulatory policy in the field of clinical trials involving human subjects; providing information relating to regulatory compliance for independent review of clinical trials involving human subjects; providing institutional biosafety committee servicesindependent review and oversight of clinical trials involving genetically engineered gene therapy and vaccine researchspecificallyreviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research; assessing the readiness of research sites to conduct gene therapy and vaccine researchreviewing standards and practices to assure compliance with laws and regulations in the field of clinical trials involving human subjects; regulatory compliance consultation services in the nature of health inspection readiness and remediation in the field of clinicalmedicalbiological research studies; consultation services in the field of pharmacovigilance strategies to ensure regulatory compliance and patient safety in the field of clinical trials involving human subjects; regulatory compliance consultation services in the field of informed consent protocols for clinical trial participants; consultation services in the field of research complianceregulatory compliance consultation services in the field of clinical trials involving human subjects
Publications
History of USPTO decisions and trademark events.
21 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
09/17/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08/15/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/15/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/04/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/04/2024
IUAF
USE AMENDMENT FILED
06/17/2024
EISU
TEAS STATEMENT OF USE RECEIVED
06/17/2024
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
06/14/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/14/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/14/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/14/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/16/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/21/2023
PUBO
PUBLISHED FOR OPPOSITION
11/21/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/01/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/18/2023
DOCK
ASSIGNED TO EXAMINER
10/10/2023
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
02/04/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/03/2023
NWAP
NEW APPLICATION ENTERED
01/17/2023
Continuous trademark protection
Get notified about every new filing that threatens BEAUFORT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.